genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Eli Lilly and Company
Artificial Intelligence
Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate
Drug Discovery
Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients
Drug Discovery
StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts
Drug Discovery
StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
Drug Discovery
StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial
Drug Discovery
HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration
Drug Discovery
StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk
Drug Discovery
StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data
Drug Discovery
Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery
FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s
1
2
3
...
9
Page 1 of 9
Scroll Up